Scott Thomas Jackson

CIK 1566617 · Chief Executive Officer · last filed 2026-05-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$272.2K

Companies

5

Total Filings

40

Lifetime Open-Market Net

$57.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MGNX Director 14,750 $3.96 $58.4K $0 12 2026-05-20
MURAV Director $0 5 2025-12-05
SPRO Director 75,000 $2.85 $213.8K $0 7 2025-06-16
CRESCENT BIOPHARMA, INC. (GLYC) Delisted Director 5,250 $15.70 $82.4K $0 7 2024-05-01
Celator Pharmaceuticals Inc (CPXX) Delisted Chief Executive Officer 0 $57.6K 8 2016-07-12

Recent Filings · Page 3 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-05-17 MGNX Grant (A) $0 EDGAR
2020-10-27 SPRO Grant (A) $0 EDGAR
2020-06-23 SPRO Grant (A) $0 EDGAR
2020-05-27 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2020-05-15 MGNX Grant (A) $0 EDGAR
2019-05-21 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2019-05-20 MGNX Grant (A) $0 EDGAR
2018-11-28 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Grant (A) $0 EDGAR
2018-05-21 MGNX Grant (A) $0 EDGAR
2017-05-22 MGNX Grant (A) $0 EDGAR
Showing 2130 of 40
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.